The award marks the 6th year in a row for recognition in this category Rahway, NJ, Jan. 18, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced CIRCUMVENT® CML has been awarded the Best New Food Animal Product from S&P Global Animal Health. It is the […]
More veterinary professionals are provided access to and are pursuing mental health resources for their overall wellbeing with continued improvements on the horizon RAHWAY, N.J., Jan. 15, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today released findings of its comprehensive Veterinary Wellbeing Study conducted in collaboration […]
Rahway, NJ, December 11, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BRAVECTO® (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. The CVMP recommends the product […]
First EU-licensed vaccine proven to protect against Cryptosporidium parvum in calves from birth onwards Rahway, N.J., Nov. 29, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has approved BOVILIS CRYPTIUM®, the first EU-licensed vaccine to protect cattle against Cryptosporidium parvum (C. parvum) […]
First cattle maternal vaccine effectively proven to protect against Cryptosporidium parvum in calves from birth onwards RAHWAY, N.J.,– Oct. 5, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BOVILIS CRYPTIUM®, […]
Company Reiterates a Commitment to Zero Dog-Mediated Human Rabies Deaths by 2030 RAHWAY, N.J., September 28, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than 5 million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. The goal […]
Symposium highlights data on an innovative, aqueous suspension of fluralaner for subcutaneous injection that was recently approved in Australia Scientific sessions highlight the importance of the One Health commitment to people, animals, environment Featured studies provide insights for otitis externa treatment, parasite prevention and infectious disease prevention RAHWAY, NJ — Sept. 27, 2023 – MSD […]
Study published in Infection and Immunity Currently no vaccine and few treatments available for cryptosporidiosis, a significant diarrheal disease in both people and animals worldwide RAHWAY, N.J., September 20, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of a new study that demonstrates […]
INNOVAX®-ILT-IBD, the first vaccine to prevent ILT, IBD, and MD in a single dose, now available in the EU, will be highlighted in a symposium Multiple studies continue to support the benefit of INNOVAX®-ND-IBD, the first vaccine against classic and variant IBD, ND and MD in a single dose RAHWAY, N.J., August 29, 2023 – […]
Gp40 antigen vaccine elicits immune response against Cryptosporidium parvum in pregnant cows to protect their newborn calves through antibodies in colostrum Combined data represent first efficacious C. parvum maternal vaccine worldwide for any species RAHWAY, N.J., August 24, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced […]